Icon

LIBRAX (nda012750)- (5MG;2.5MG)

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE BAUSCH
5MG;2.5MG
No No
Expired Expired
None None
None No
Librax is indicated to control emotional and somatic factors in gastrointestinal disorders. Librax may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
13 0 10
Total Other Developers 17
Drugs with Suitability No
5MG;2.5MG ** ** - - 9
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******* ***************, *** *********** ***** ******* **** ***** ***, *****, ******* (**) *****, ****** ****** (***) ***
****** ******* ******* ***************, *** *********** **** ***** ***** ** *** ***, *****, ******* (**) *****, ****** ****** (***) ***
****** **** ****** *** ******* ************** *** *********** *** **** ******* ******, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ********* ** *** *************** *** *********** **** ** **** *******, **. **********, ******* (**) *****, ****** ****** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***
****** ** ****** **. *****'* ************ ******* *********** ***-*** - ******* **** - **, ****** ** ******,**,**&**, ****** ** * ** ** & ** ** **, **************** ******* ***********(*),, **********, ****** ******* ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** ***** **** ***** **** ******* *********** **** **. *-*** ** *-*** & **, ***** *** & ***** **, ***** ********** ******, *****, *** ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.